ADIPOQ and Hepatic steatosis: Meanwhile, silybin confers resistance to hepatic steatosis, dyslipidemia, and inflammatory cell infiltration in vivo [104,141], which might be attributed to the reduced expression of TNF-α and IL-1β and the enhanced expression of anti-inflammatory factors IL-10 and adiponectin in adipose tissue [104].